Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
Journal Of Systems And Integrative Neuroscience
Blum, K K; Bowirrat, A A; Baron, D D; Lott, L L; Ponce, J V JV; Brewer, R R; Siwicki, D D; Boyett, B B; Gondre-Lewis, M C MC; Smith, D E DE; Panayotis K, Thanos T; Badgaiyan, S S; Hauser, M M; Fried, L L; A, Roy R; Downs, B W BW; Badgaiyan, R D RD
Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review.
Molecular Neurobiology
Misiak, Błażej B; Stramecki, Filip F; Gawęda, Łukasz Ł; Prochwicz, Katarzyna K; Sąsiadek, Maria M MM; Moustafa, Ahmed A AA; Frydecka, Dorota D
Oquendo, Maria A MA; Sullivan, Gregory M GM; Sudol, Katherin K; Baca-Garcia, Enrique E; Stanley, Barbara H BH; Sublette, M Elizabeth ME; Mann, J John JJ
The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis.
Translational Psychiatry
Clayden, R C RC; Zaruk, A A; Meyre, D D; Thabane, L L; Samaan, Z Z
Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.
The Journal Of Pain
Smith, Shad B SB; Maixner, Dylan W DW; Greenspan, Joel D JD; Dubner, Ronald R; Fillingim, Roger B RB; Ohrbach, Richard R; Knott, Charles C; Slade, Gary D GD; Bair, Eric E; Gibson, Dustin G DG; Zaykin, Dmitri V DV; Weir, Bruce S BS; Maixner, William W; Diatchenko, Luda L
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Trials
Williams, Leanne M LM; Rush, A John AJ; Koslow, Stephen H SH; Wisniewski, Stephen R SR; Cooper, Nicholas J NJ; Nemeroff, Charles B CB; Schatzberg, Alan F AF; Gordon, Evian E